CV Sciences (CVSI) Change in Account Payables (2011 - 2013)
CV Sciences' (CVSI) quarterly Change in Account Payables came in at $280538.0 in Q1 2013, up 2825.01% year-on-year from $9591.0 in Q1 2012, and up 1140.76% quarter-over-quarter from -$26955.0 in Q4 2012.
CV Sciences (CVSI) Change in Account Payables (2011 - 2013) Analysis & Trends
CV Sciences has disclosed Change in Account Payables across 3 years of filings, most recently posting $280538.0 for Q1 2013.
- Change in Account Payables for Q1 2013 came in at $280538.0, up 2825.01% year-over-year; the trailing twelve-month figure through Mar 2013 was $250724.0 (up 1287.52% YoY), and the FY2015 annual result was $113021.0, down 40.78% from the prior year.
- Change in Account Payables came in at $280538.0 for Q1 2013 at CV Sciences, up from -$26955.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $280538.0 in Q1 2013 to a low of -$26955.0 in Q4 2012.
- The 3-year median for Change in Account Payables is $3386.0 (2011), against an average of $31170.9.
- Across the five-year window, Change in Account Payables plunged 178.46% in 2012 and soared 2825.01% in 2013, its largest moves.
- CV Sciences' Change in Account Payables stood at -$9680.0 in 2011, then plunged by 178.46% to -$26955.0 in 2012, then jumped by 1140.76% to $280538.0 in 2013.
- The last three Change in Account Payables figures came in at $280538.0 (Q1 2013), -$26955.0 (Q4 2012), and -$2411.0 (Q3 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | CV Sciences | - | - | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 280,538.00 |
| Mar 31, 2013 | 280,538.00 |
| Dec 31, 2012 | -26,955.00 |
| Dec 31, 2012 | -26,955.00 |
| Sep 30, 2012 | -2,411.00 |
| Sep 30, 2012 | -2,411.00 |
| Jun 30, 2012 | -448.00 |
| Jun 30, 2012 | -448.00 |
| Mar 31, 2012 | 9,591.00 |
| Mar 31, 2012 | 9,591.00 |
| Dec 31, 2011 | -9,680.00 |
| Dec 31, 2011 | -9,680.00 |
| Sep 30, 2011 | 14,773.00 |
| Sep 30, 2011 | 14,773.00 |
| Jun 30, 2011 | 3,386.00 |
| Jun 30, 2011 | 3,386.00 |
| Mar 31, 2011 | 11,744.00 |
| Mar 31, 2011 | 11,744.00 |